A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy
Clinical trial NCT06927375 · RECRUITING
Trial details
- NCT number
- NCT06927375
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2025-11-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.